Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 4/2021

Inhalt (27 Artikel)

Combination therapies utilizing neoepitope-targeted vaccines

  • Open Access
  • Review

Karin L. Lee, Jeffrey Schlom, Duane H. Hamilton

Are all cytokine storms the same?

Nicki Panoskaltsis

Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma

  • Open Access
  • Original Article

Katharina Leuchte, Elena Staib, Martin Thelen, Philipp Gödel, Axel Lechner, Peter Zentis, Maria Garcia-Marquez, Dirk Waldschmidt, Rabi Raj Datta, Roger Wahba, Christian Wybranski, Thomas Zander, Alexander Quaas, Uta Drebber, Dirk Ludger Stippel, Christiane Bruns, Michael von Bergwelt-Baildon, Kerstin Wennhold, Hans Anton Schlößer

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity

  • Original Article

Rosmely Hernandez, Kevin H. Toomer, Janika Põder, Alicia Santos Savio, Sunnie Hsiung, Thomas R. Malek

A pan-cancer analysis of the human tumor coagulome and its link to the tumor immune microenvironment

  • Original Article

Zuzana Saidak, Simon Soudet, Marine Lottin, Valéry Salle, Marie-Antoinette Sevestre, Florian Clatot, Antoine Galmiche

Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review

  • Open Access
  • Original Article

Aasir M. Suliman, Shaza A. Bek, Mohamed S. Elkhatim, Ahmed A. Husain, Ahmad Y. Mismar, M. Z. Sharaf Eldean, Zsolt Lengyel, Shereen Elazzazy, Kakil I. Rasul, Nabil E. Omar

Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial

  • Original Article

Hiroto Matsui Matsui, Shoichi Hazama, Masao Nakajima, Ming Xu, Satoshi Matsukuma, Yukio Tokumitsu, Yoshitaro Shindo, Shinobu Tomochika, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shigefumi Yoshino, Tomio Ueno, Masaaki Oka, Hiroaki Nagano

Correction to: Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial

  • Correction

Hiroto Matsui, Shoichi Hazama, Masao Nakajima, Ming Xu, Satoshi Matsukuma, Yukio Tokumitsu, Yoshitaro Shindo, Shinobu Tomochika, Shin Yoshida, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Shigefumi Yoshino, Tomio Ueno, Masaaki Oka, Hiroaki Nagano

Overcoming acquired resistance to PD-1 inhibitor with the addition of metformin in small cell lung cancer (SCLC)

  • Original Article

Yeseul Kim, Elena Vagia, Pedro Viveiros, Cyra Y. Kang, Ju Young Lee, Gahyun Gim, Sukjoo Cho, Horyun Choi, Leeseul Kim, Inae Park, Jaeyoun Choi, Young Kwang Chae

An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinoma

  • Original Article

Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang

Notch signaling defects in NK cells in patients with cancer

  • Original Article

Gulnur K. Zakiryanova, Elena Kustova, Nataliya T. Urazalieva, Emile T. Baimukhametov, Valeriy A. Makarov, Gulmariya M. Turaly, Galina V. Shurin, Zarema M. Biyasheva, Narymzhan N. Nakisbekov, Michael R. Shurin

Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide

  • Original Article

Ayman J. Oweida, Adam C. Mueller, Miles Piper, Dallin Milner, Benjamin Van Court, Shilpa Bhatia, Andy Phan, Thomas Bickett, Kimberly Jordan, Theresa Proia, Richard Schulick, Wells A. Messersmith, Marco Del Chiaro, Eric Clambey, Michael J. Gough, Jason Williams, Kirk Hansen, Karyn Goodman, Sana D. Karam

Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers

  • Original Article

Wei Zhang, Junping Shi, Yingying Wang, Hongyuan Zhou, Zewu Zhang, Zhiqiang Han, Guanghao Li, Bo Yang, Guangtai Cao, Yan Ke, Ti Zhang, Tianqiang Song, QiangLi

OSCC cell-secreted exosomal CMTM6 induced M2-like macrophages polarization via ERK1/2 signaling pathway

  • Original Article

Xin Pang, Sha-sha Wang, Mei Zhang, Jian Jiang, Hua-yang Fan, Jia-shun Wu, Hao-fan Wang, Xin-hua Liang, Ya-ling Tang

Merkel cell carcinoma in Latin America: a contribution from an expanded access program for avelumab to address issues from experts’ recommendations

  • Original Article

Rodrigo Ramella Munhoz, Federico Cayol, Luis Corrales, Raquel Gerson, Malena Tilli, Elluz Oliver Barreto, Jesús Oswaldo Sánchez Castillo, Rafael Aron Schmerling, Gabriela Cinat

Retinoblastoma cell-derived Twist protein promotes regulatory T cell development

  • Original Article

Ruishi Zhang, Yan-Nan Song, Xiaoyan Duo, Zhihong Guo, Yanhua Sun, Zhixiong Zhang, Yongtian Lu, Beiping Miao, Ping-Chang Yang, Guohui Nie

PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model

  • Original Article

Shiwen Peng, Marietta Tan, Yen-Der Li, Max A. Cheng, Emily Farmer, Louise Ferrall, Stephanie Gaillard, Richard B. S. Roden, Chien-Fu Hung, T.-C. Wu

Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancer

  • Original Article

Koji Teramoto, Tomoyuki Igarashi, Yoko Kataoka, Mitsuaki Ishida, Jun Hanaoka, Hidetoshi Sumimoto, Yataro Daigo

Improvement of DC-based vaccines using adjuvant TLR4-binding 60S acidic ribosomal protein P2 and immune checkpoint inhibitors

  • Original Article

Gun-Young Jang, Young Seob Kim, Sung Eun Lee, Ji won Lee, Hee Dong Han, Tae Heung Kang, Yeong-Min Park

Prognostic role of gamma-glutamyl transferase in metastatic melanoma patients treated with immune checkpoint inhibitors

  • Original Article

Johanna Winter, Max M. Lenders, Maximilian Gassenmaier, Andrea Forschner, Ulrike Leiter, Benjamin Weide, Mette-Triin Purde, Lukas Flatz, Antonio Cozzio, Martin Röcken, Claus Garbe, Thomas K. Eigentler, Nikolaus B. Wagner

Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity

  • Open Access
  • Original Article

Simone Punt, Shruti Malu, Jodi A. McKenzie, Soraya Zorro Manrique, Elien M. Doorduijn, Rina M. Mbofung, Leila Williams, Deborah A. Silverman, Emily L. Ashkin, Ana Lucía Dominguez, Zhe Wang, Jie Qing Chen, Sourindra N. Maiti, Trang N. Tieu, Chengwen Liu, Chunyu Xu, Marie-Andrée Forget, Cara Haymaker, Jahan S. Khalili, Nikunj Satani, Florian Muller, Laurence J. N. Cooper, Willem W. Overwijk, Rodabe N. Amaria, Chantale Bernatchez, Timothy P. Heffernan, Weiyi Peng, Jason Roszik, Patrick Hwu

Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm

  • Original Article

Nicki Panoskaltsis, Neil E. McCarthy, Andrew J. Stagg, Catherine J. Mummery, Mariwan Husni, Naila Arebi, David Greenstein, Claire L. Price, Hafid O. Al-Hassi, Michalis Koutinas, Athanasios Mantalaris, Stella C. Knight

Patients with gastrointestinal irritability after TGN1412-induced cytokine storm displayed selective expansion of gut-homing αβ and γδT cells

  • Original Article

Neil E. McCarthy, Andrew J. Stagg, Claire L. Price, Elizabeth R. Mann, Nichola L. Gellatly, Hafid O. Al-Hassi, Stella C. Knight, Nicki Panoskaltsis

Myelopoiesis of acute inflammation: lessons from TGN1412-induced cytokine storm

  • Research Report

Nicki Panoskaltsis, Neil E. McCarthy, Stella C. Knight

Selective CD47 targeting with a bispecific antibody

  • Letter to the Editors

Walter Ferlin, Krzysztof Masternak, Limin Shang

Correction to: In-depth characterization of the tumor microenvironment in central nervous system lymphoma reveals implications for immune-checkpoint therapy

  • Correction

Lukas Marcelis, Asier Antoranz, Anne-Marie Delsupehe, Pauline Biesemans, Julio Finalet Ferreiro, Koen Debackere, Peter Vandenberghe, Gregor Verhoef, Paul Clement, Steven De Vleeschouwer, Olivier Gheysens, Giorgio Cattoretti, Francesca Maria Bosisio, Xavier Sagaert, Daan Dierickx, Thomas Tousseyn

Neu im Fachgebiet Onkologie

Vorteile für TFOX bei HER2-negativem Magenkrebs

TFOX – ein modifiziertes FLOT-Schema – ist bei fortgeschrittenem HER2-negativem Magenkrebs offenbar wirksamer als FOLFOX: Sowohl das progressionsfreie Überleben als auch das Gesamtüberleben werden durch TFOX deutlich verlängert. Jedoch profitieren nicht alle von dieser Triplet-Therapie.

Alternde Blutbildung lässt solide Tumoren wachsen

Bestimmte mutierte Blutzellen erhöhen nicht nur das Risiko für hämatologische Neoplasien, sondern sind offenbar auch bei soliden Tumoren prognostisch ungünstig. Dafür sprechen aktuelle Erkenntnisse, insbesondere beim nichtkleinzelligen Lungenkarzinom.

ctDNA erkennt minimale Resterkrankung beim Melanom

Die Diagnose einer minimalen Resterkrankung mithilfe zirkulierender Tumor-DNA (ctDNA) könnte auch das Management von Patientinnen und Patienten mit Melanomen im Stadium III bereichern, wie Ergebnisse einer Studie nahelegen – auch wenn die Methode noch nicht perfekt funktioniert.

Höhere Dosis von Dexamethason senkt Überlebenschancen

Personen mit Hirnmetastasen, die perioperativ höhere kumulative Dosen von Dexamethason erhalten, haben eine schlechtere Prognose. Um die Ergebnisse zu verbessern, bedarf es strengerer Dosierungsschemata.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.